A detailed history of Diversify Wealth Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Diversify Wealth Management, LLC holds 9,439 shares of HALO stock, worth $575,590. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,439
Previous 7,331 28.75%
Holding current value
$575,590
Previous $382 Million 25.52%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$51.3 - $64.42 $108,140 - $135,797
2,108 Added 28.75%
9,439 $480 Million
Q2 2024

Aug 08, 2024

BUY
$37.81 - $52.4 $277,185 - $384,144
7,331 New
7,331 $382 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.49B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Diversify Wealth Management, LLC Portfolio

Follow Diversify Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversify Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversify Wealth Management, LLC with notifications on news.